| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) | 
|---|
| 08/12/2010 | WO2010089544A1 Actagardine derivatives | 
| 08/12/2010 | WO2010089019A1 Compounds comprising n-formyl-methionine residues and tumor-targeting peptides | 
| 08/12/2010 | WO2010088803A1 New porcine reproductive and respiratory syndrome virus receptor, and blockers thereof | 
| 08/12/2010 | US20100204448 Method and carrier complexes for delivering molecules to cells | 
| 08/12/2010 | US20100204444 Multifunctional protein simultaneously delivering antibodies and nanoparticles | 
| 08/12/2010 | US20100204297 Influenza therapeutic | 
| 08/12/2010 | US20100204157 Use of a peptide as a therapeutic agent | 
| 08/12/2010 | US20100204156 Use of thymopentin as a therapeutic agent | 
| 08/12/2010 | US20100204154 Use of the peptide rfmwmr as a therapeutic agent | 
| 08/12/2010 | US20100204151 Use of a peptide as a therapeutic agent | 
| 08/12/2010 | US20100204149 Use of octreotide as a therapeutic agent | 
| 08/12/2010 | US20100204148 (d-leu7 ) -histrelin as a therapeutic agent | 
| 08/12/2010 | US20100204142 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent | 
| 08/12/2010 | US20100204141 Use of bpp-b as a therapeutic agent | 
| 08/12/2010 | US20100204140 Use of a peptide as a therapeutic agent | 
| 08/12/2010 | US20100204136 Use of a peptide as a therapeutic agent | 
| 08/12/2010 | US20100204130 Use of human neuropeptide as a therapeutic agent | 
| 08/12/2010 | US20100204128 Novel peptides | 
| 08/12/2010 | US20100204103 Helical synthetic peptides that stimulate cellular cholesterol efflux | 
| 08/12/2010 | US20100204090 Use of a peptide as a therapeutic agent | 
| 08/12/2010 | US20100204088 Cyclic Peptide Antitumor Agents | 
| 08/12/2010 | US20100203612 Specific peptide binding to glypican-3 | 
| 08/12/2010 | US20100203570 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells | 
| 08/12/2010 | US20100203568 Assay Method For Peptide Specific T-Cells | 
| 08/12/2010 | US20100203565 Peptide Fingerprint from the Degradation of Elastin by HNE | 
| 08/12/2010 | US20100203559 Immuno-Based Botulinum Toxin Serotype A Activity Assays | 
| 08/12/2010 | US20100203135 Skin Equivalent Culture | 
| 08/12/2010 | US20100203120 Pharmaceutical cyclosporin compositions | 
| 08/12/2010 | US20100203109 Methods and Compositions for Treating Melanoma | 
| 08/12/2010 | US20100203080 Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof | 
| 08/12/2010 | US20100203066 Polymeric linkers containing pyridyl disulfide moieties | 
| 08/12/2010 | US20100202967 Fibrin binding pepetide conjugates for diagnostic and therapeutic applications | 
| 08/12/2010 | CA2751500A1 Grass peptides for vaccine | 
| 08/12/2010 | CA2750883A1 Actagardine derivatives | 
| 08/12/2010 | CA2749965A1 Methods and compositions for treating neuropathies | 
| 08/12/2010 | CA2748314A1 Extended recombinant polypeptides and compositions comprising same | 
| 08/11/2010 | EP2215111A2 Hla-dr binding peptides and their uses | 
| 08/11/2010 | EP2215108A2 Competitive inhibitors of invariant chain expression and/or ectopic clip binding | 
| 08/11/2010 | EP2215107A1 Peptide ligand directed drug delivery | 
| 08/11/2010 | EP1911763B1 Compositions for the treatment of gastrointestinal disorders | 
| 08/11/2010 | CN101801995A antibiotic peptides | 
| 08/11/2010 | CN101801340A Cationic peptide for delivering an agent into a cell | 
| 08/11/2010 | CN101798338A Anti-opioid peptide antagonist peptide and application thereof | 
| 08/11/2010 | CN101798337A Mutant of endotoxin neutralizing peptide and application thereof | 
| 08/11/2010 | CN101798336A Anti-tumour compound with tracking function | 
| 08/11/2010 | CN101797384A Tri-union compound immunopotentiator and method for preparing same | 
| 08/11/2010 | CN101797382A Anti-human progastrin polypeptide immune composition | 
| 08/11/2010 | CN101161674B Cyclopeptide, preparation method and uses thereof | 
| 08/11/2010 | CN101007845B Method for screening high egg-yield fowl | 
| 08/11/2010 | CN100999546B Polypeptide compound with aza-containing heterocyclic modification and its application | 
| 08/10/2010 | US7772189 drug delivery to liver tissue of a complex or conjugate of drug and polypeptide comprising the amino acid sequence of SEQ ID NO:61; biodrug is siRNA molecule | 
| 08/10/2010 | US7772188 Methods and compositions for the treatment of gastrointestinal disorders | 
| 08/10/2010 | US7772187 Substances directed against a specific sequence essential for heparanase catalytic activity and uses thereof as heparanase inhibitors | 
| 08/10/2010 | US7771966 Polypeptide cleavage process | 
| 08/10/2010 | US7771727 Conjugates of therapeutic or cytotoxic agents and biologically active peptides | 
| 08/10/2010 | CA2489167C Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit | 
| 08/10/2010 | CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof | 
| 08/10/2010 | CA2124583C Synthetic compounds and compositions with enhanced cell binding | 
| 08/05/2010 | WO2010087480A1 Pharmaceutical preparation or food containing peptide | 
| 08/05/2010 | WO2010086475A1 Set of primers, probes, a method and a kit for the detection and differentiation of dna sequences specific to brucella spp. and mycobacterium tuberculosis complex | 
| 08/05/2010 | WO2010086401A1 Antibiotic peptides | 
| 08/05/2010 | WO2010086337A1 Novel peptide-homologues for inhibiting beta1-adrenoceptor antibodies | 
| 08/05/2010 | WO2010086294A2 Pan-dr binding polypeptides and uses thereof | 
| 08/05/2010 | US20100199361 Role of Proteoglycans in Drug Dependence | 
| 08/05/2010 | US20100197891 Method for peptide synthesis | 
| 08/05/2010 | US20100197889 Polypeptide as standard for proteome analysis | 
| 08/05/2010 | US20100197607 Mucin hypersecretion inhibitors and methods of use | 
| 08/05/2010 | US20100197606 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus | 
| 08/05/2010 | US20100197604 Use of peptide as a therapeutic agent | 
| 08/05/2010 | US20100197602 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection | 
| 08/05/2010 | US20100197598 Novel macromolecule transduction domains and methods for identification and uses thereof | 
| 08/05/2010 | US20100197576 Polypeptides or fusion proteins thereof inhibiting transmigration of leucocytes or growth and/or metastasis of cancer cells | 
| 08/05/2010 | US20100197570 Cyclodepsipeptides with Antineoplastic Activity and Methods of Using to Inhibit Cancer and Microbial Growth | 
| 08/05/2010 | US20100197569 Cross-linked glycopeptide-cephalosporin antibiotics | 
| 08/05/2010 | US20100197185 Low and ultra-low formaldehyde emission binders for non-woven glass mat | 
| 08/05/2010 | US20100197040 Assays for preimplantation factor and preimplantation factor peptides | 
| 08/05/2010 | US20100196919 Peptides, antibodies and fragments thereof for the treatment and diagnostic of celiac disease | 
| 08/05/2010 | US20100196458 Modified cytokines for use in cancer therapy | 
| 08/05/2010 | US20100196381 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use | 
| 08/05/2010 | US20100196317 Cyclic undecapeptides and derivatives as multiple sclerosis therapies | 
| 08/05/2010 | US20100196271 Cage-Like Bifunctional Chelators, Copper-64 Radiopharmaceuticals and PET Imaging Using the Same | 
| 08/05/2010 | US20100196270 Radiofluorination methods | 
| 08/05/2010 | DE102009007381A1 Antibiotische Peptide Antimicrobial peptides | 
| 08/05/2010 | CA2751010A1 Antibiotic peptides | 
| 08/04/2010 | EP2213740A1 Human telomerase catalytic subunit | 
| 08/04/2010 | EP2213297A1 Staphylococcus aureus antigenic polypeptides | 
| 08/04/2010 | EP2212349A1 Synthetic analogues of neural regeneration peptides | 
| 08/04/2010 | EP2212343A2 Peptide gap junction modulators | 
| 08/04/2010 | EP2211891A2 Antagonists of kisspeptin and uses thereof | 
| 08/04/2010 | EP2211889A2 Antibody-mediated disruption of quorum sensing in bacteria | 
| 08/04/2010 | EP1636365B1 Cholesterol biosynthesis pathway modulators and uses thereof | 
| 08/04/2010 | CN1896094B Use of angiotensin II receptors I immunogenic peptide section | 
| 08/04/2010 | CN101796067A Lantibiotic-based compounds having antimicrobial activity | 
| 08/04/2010 | CN101796064A Method for producing peptide | 
| 08/04/2010 | CN101795701A Inhibitors of acetyl-COA carboxylase for treatment of neuronal hypometabolism | 
| 08/04/2010 | CN101792487A Method for synthesizing Laterocidin compound by solid phase cyclization | 
| 08/04/2010 | CN101792486A Method for combining caspofungin acetate | 
| 08/04/2010 | CN101792485A Alpha-type conus polypeptide and application thereof | 
| 08/04/2010 | CN101792484A Anthracycline derivative of polypeptide containing tyrosine-isoleucine-glycine-serine-arginine | 
| 08/04/2010 | CN101792483A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus |